Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Filters
Bruce Armitage
Professor and Co-DirectorCarnegie Mellon University
Bruce Armitage’s current research interests include the use of PNA for sequence-specific recognition of DNA and RNA.
John McCulloch
Founder & Managing DirectorBurloch Group Inc.
Engaging and knowledgeable speaker with deep expertise in biotechnology investment.
Robert Lanza
ScientistOcata Therapeutics
Robert Lanza is currently Chief Scientific Officer at Ocata Therapeutics and Adjunct Professor at Wake Forest University School of Medicine.
Riccardo Panicucci
Senior VP CMCQED Therapeutics and Origin Biosciences
Riccardo Panicucci is an expert in the pharmaceutical industry, biotechnology, clinical development, and biopharmaceuticals.
Dr. Mark Ware
Chief Medical OfficerCanopy Growth
Dr. Ware leads Canopy Growth’s medical division, Spectrum Therapeutics including research towards the development of cannabinoid medicines.
Andrew Lover
Associate Professor of Epidemiology and Deputy Director, New England Center of Excellence in Vector-Borne DiseaseUniversity of Massachusetts Amherst
Andrew Lover is an infectious disease epidemiologist whose work focuses on malaria and other vector-borne diseases.
Emily Walsh
Principal ConsultantHalloran Consulting Group, Inc.
Recovering Scientist
Avak Kahvejian
Partner, VentureLabsFlagship Pioneering
Avak Kahvejian is an expert in conceiving and launching internally generated platform companies and leveraging new biological mechanisms.
Paulina Hill
PrincipalOmega Funds
Paulina Hill is a healthcare investor who has expertise in biotechnology, molecular biology, cell culture and entrepreneurship.
Robert Kemp
VP of Market Access and HEORBreath Therapeutics
Robert Kemp is an expert at developing value strategies using clinical and economic information.